Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
49.52
-1.28 (-2.52%)
Mar 27, 2026, 4:00 PM EDT - Market closed

Supernus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,8512,8562,0161,5841,9351,553
Market Cap Growth
63.90%41.67%27.28%-18.16%24.62%16.75%
Enterprise Value
2,5842,5771,5891,3621,9121,634
Last Close Price
49.5249.7036.1628.9435.6729.16
PE Ratio
--73.0927.391447.0034.3029.76
Forward PE
20.9419.3319.6515.3430.8415.73
PEG Ratio
1.171.111.111.111.111.11
PS Ratio
3.973.973.052.612.902.68
PB Ratio
2.682.691.951.722.181.90
P/TBV Ratio
2.632.641.951.742.481.94
P/FCF Ratio
62.0062.0911.7714.3316.6212.42
P/OCF Ratio
60.2460.3311.7214.2616.5712.22
EV/Sales Ratio
3.593.582.402.242.872.82
EV/EBITDA Ratio
58.1988.029.8117.1114.5213.77
EV/EBIT Ratio
--41.3819.46-258.5041.4518.99
EV/FCF Ratio
56.1856.049.2812.3216.4213.06
Debt / Equity Ratio
0.030.030.030.040.490.52
Debt / EBITDA Ratio
1.041.040.170.423.333.55
Debt / FCF Ratio
0.660.660.160.303.763.36
Net Debt / Equity Ratio
-0.26-0.26-0.41-0.24-0.030.10
Net Debt / EBITDA Ratio
-9.51-9.51-2.63-2.78-0.180.68
Net Debt / FCF Ratio
-6.05-6.05-2.49-2.01-0.200.65
Asset Turnover
0.510.510.500.410.390.36
Inventory Turnover
1.091.091.180.990.981.12
Quick Ratio
1.471.472.041.380.911.55
Current Ratio
1.901.902.351.701.071.91
Return on Equity (ROE)
-3.68%-3.68%7.55%0.15%7.13%6.85%
Return on Assets (ROA)
-3.47%-3.47%4.66%-0.17%2.72%3.93%
Return on Invested Capital (ROIC)
-6.34%-6.34%8.45%-0.28%4.41%6.36%
Return on Capital Employed (ROCE)
-5.69%-5.69%7.92%-0.53%3.86%6.54%
Earnings Yield
-1.35%-1.37%3.65%0.07%2.92%3.36%
FCF Yield
1.61%1.61%8.49%6.98%6.02%8.05%
Buyback Yield / Dilution
-0.88%-0.88%-0.81%10.01%-13.47%-1.24%
Total Shareholder Return
-0.88%-0.88%-0.81%10.01%-13.47%-1.24%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q